The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family

The cholix toxin gene (chxA) was first identified in V. cholerae strains in 2007, and the protein was identified by bioinformatics analysis in 2008. It was identified as the third member of the diphtheria toxin group of mono-ADP-ribosyltransferase toxins along with P. aeruginosa exotoxin A and C. di...

Full description

Bibliographic Details
Main Authors: Miguel R. Lugo, A. Rod Merrill
Format: Article
Language:English
Published: MDPI AG 2015-07-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/7/8/2757
_version_ 1828280652172099584
author Miguel R. Lugo
A. Rod Merrill
author_facet Miguel R. Lugo
A. Rod Merrill
author_sort Miguel R. Lugo
collection DOAJ
description The cholix toxin gene (chxA) was first identified in V. cholerae strains in 2007, and the protein was identified by bioinformatics analysis in 2008. It was identified as the third member of the diphtheria toxin group of mono-ADP-ribosyltransferase toxins along with P. aeruginosa exotoxin A and C. diphtheriae diphtheria toxin. Our group determined the structure of the full-length, three-domain cholix toxin at 2.1 Å and its C-terminal catalytic domain (cholixc) at 1.25 Å resolution. We showed that cholix toxin is specific for elongation factor 2 (diphthamide residue), similar to exotoxin A and diphtheria toxin. Cholix toxin possesses molecular features required for infection of eukaryotes by receptor-mediated endocytosis, translocation to the host cytoplasm and inhibition of protein synthesis. More recently, we also solved the structure of full-length cholix toxin in complex with NAD+ and proposed a new kinetic model for cholix enzyme activity. In addition, we have taken a computational approach that revealed some important properties of the NAD+-binding pocket at the residue level, including the role of crystallographic water molecules in the NAD+ substrate interaction. We developed a pharmacophore model of cholix toxin, which revealed a cationic feature in the side chain of cholix toxin active-site inhibitors that may determine the active pose. Notably, several recent reports have been published on the role of cholix toxin as a major virulence factor in V. cholerae (non-O1/O139 strains). Additionally, FitzGerald and coworkers prepared an immunotoxin constructed from domains II and III as a cancer treatment strategy to complement successful immunotoxins derived from P. aeruginosa exotoxin A.
first_indexed 2024-04-13T08:02:22Z
format Article
id doaj.art-50e709db27424820a56caf82d3927c09
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-13T08:02:22Z
publishDate 2015-07-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-50e709db27424820a56caf82d3927c092022-12-22T02:55:15ZengMDPI AGToxins2072-66512015-07-01782757277210.3390/toxins7082757toxins7082757The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin FamilyMiguel R. Lugo0A. Rod Merrill1Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, CanadaDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, CanadaThe cholix toxin gene (chxA) was first identified in V. cholerae strains in 2007, and the protein was identified by bioinformatics analysis in 2008. It was identified as the third member of the diphtheria toxin group of mono-ADP-ribosyltransferase toxins along with P. aeruginosa exotoxin A and C. diphtheriae diphtheria toxin. Our group determined the structure of the full-length, three-domain cholix toxin at 2.1 Å and its C-terminal catalytic domain (cholixc) at 1.25 Å resolution. We showed that cholix toxin is specific for elongation factor 2 (diphthamide residue), similar to exotoxin A and diphtheria toxin. Cholix toxin possesses molecular features required for infection of eukaryotes by receptor-mediated endocytosis, translocation to the host cytoplasm and inhibition of protein synthesis. More recently, we also solved the structure of full-length cholix toxin in complex with NAD+ and proposed a new kinetic model for cholix enzyme activity. In addition, we have taken a computational approach that revealed some important properties of the NAD+-binding pocket at the residue level, including the role of crystallographic water molecules in the NAD+ substrate interaction. We developed a pharmacophore model of cholix toxin, which revealed a cationic feature in the side chain of cholix toxin active-site inhibitors that may determine the active pose. Notably, several recent reports have been published on the role of cholix toxin as a major virulence factor in V. cholerae (non-O1/O139 strains). Additionally, FitzGerald and coworkers prepared an immunotoxin constructed from domains II and III as a cancer treatment strategy to complement successful immunotoxins derived from P. aeruginosa exotoxin A.http://www.mdpi.com/2072-6651/7/8/2757cholix toxinelongation factor 2ADP-ribosylationinhibitor developmentcomputational chemistry
spellingShingle Miguel R. Lugo
A. Rod Merrill
The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family
Toxins
cholix toxin
elongation factor 2
ADP-ribosylation
inhibitor development
computational chemistry
title The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family
title_full The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family
title_fullStr The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family
title_full_unstemmed The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family
title_short The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family
title_sort father son and cholix toxin the third member of the dt group mono adp ribosyltransferase toxin family
topic cholix toxin
elongation factor 2
ADP-ribosylation
inhibitor development
computational chemistry
url http://www.mdpi.com/2072-6651/7/8/2757
work_keys_str_mv AT miguelrlugo thefathersonandcholixtoxinthethirdmemberofthedtgroupmonoadpribosyltransferasetoxinfamily
AT arodmerrill thefathersonandcholixtoxinthethirdmemberofthedtgroupmonoadpribosyltransferasetoxinfamily
AT miguelrlugo fathersonandcholixtoxinthethirdmemberofthedtgroupmonoadpribosyltransferasetoxinfamily
AT arodmerrill fathersonandcholixtoxinthethirdmemberofthedtgroupmonoadpribosyltransferasetoxinfamily